Related Experiment Video
Updated: Jul 27, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Association between metabolic syndrome and stroke: a population based cohort study
Amir Moghadam-Ahmadi1,2,3, Narjes Soltani4, Fatemeh Ayoobi5
1Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Metabolic syndrome (MetS) significantly increases stroke risk across multiple diagnostic criteria. Early identification and management of MetS are crucial for preventing strokes.
Area of Science:
- Epidemiology
- Cardiovascular Health
- Metabolic Disorders
Background:
- Metabolic syndrome (MetS) and stroke are significant contributors to mortality.
- Understanding the prevalence of MetS and its association with stroke is vital for public health.
Purpose of the Study:
- To determine the prevalence of MetS in Iranian adults using three distinct definitions.
- To investigate the association between MetS and the risk of stroke.
Main Methods:
- A cross-sectional study involving 9991 adults from the Rafsanjan Cohort Study (PERSIAN cohort).
- Prevalence assessment using Adult Treatment Panel III (ATP-III), International Diabetes Federation (IDF), and Iranian IDF criteria.
- Multivariate logistic regression and ROC curve analysis to assess the association with stroke.
Main Results:
- MetS was significantly associated with increased odds of stroke across all three definitions (ATP-III, IDF, Iranian IDF).
- Odds ratios ranged from 1.48 to 1.89 after adjusting for confounders.
- Receiver operating characteristic (ROC) curve analysis indicated moderate accuracy in identifying increased stroke risk for all MetS criteria.
Conclusions:
- Metabolic syndrome is a significant risk factor for stroke.
- The findings underscore the importance of early detection, treatment, and prevention strategies for MetS to mitigate stroke risk.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Coronary Artery Disease I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypertension II: Pathophysiology